ATS View
한국어

Curocell KRX:372320KOSDAQ

큐로셀 · Korean news coverage and regulatory filings, organized.

한국어
Articles, 24h0
Articles, 7 days2
DART filings, 7 days1
Articles tracked22since Sep 11

In Q2 2026, Curocell reported revenue of ₩0m and an operating loss of ₩9.7bn. Curocell (큐로셀) appeared in 2 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Oct 22 with 18 articles. The most common catalyst was policy & overseas (3).

Filing signals Insider buying Clinical trial filing 4 quarters of losses Screener

Curocell quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩0m–−₩9.7bn−₩17.6bn
Q1 2026₩0m–−₩7.8bn−₩8.7bn
Q4 2025 derived₩0m–−₩8.7bn−₩17.5bn
Q3 2025₩0m–−₩9.2bn−₩10.2bn
Q2 2025₩0m–−₩12.1bn−₩11.8bn
Q1 2025₩0m–−₩6.2bn−₩6.8bn
Q4 2024 derived₩0m–−₩10.0bn−₩10.5bn
Q3 2024₩0m–−₩10.0bn−₩10.4bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Curocell top stories 2 weeks, by number of outlets

  1. 1
    큐로셀, CAR-T 치료제 ‘림카토’ 임상제조소에 튀르키예 보건부 장관 방문
    8 outlets · 8 articlesFirst report Oct 22 09:32 더바이오
  2. 2
    튀르키예 보건장관, 큐로셀 방문…CAR-T '림카토' 해외진출 모색
    2 outlets · 2 articlesFirst report Oct 22 09:59 뉴스1Overseas expansion
  3. 3
    큐로셀, 튀르키예 정부와 CAR-T 치료제 현지 도입 논의
    2 outlets · 2 articlesFirst report Oct 22 09:43 메디파나뉴스
  4. 4
    큐로셀 "임상제조소에 튀르키예 보건부장관 방문"
    2 outlets · 2 articlesFirst report Oct 22 10:30 뉴시스경제
  5. 5
    큐로셀, '안발셀' 성인 급성 림프모구성 백혈병 임상 1·2상 계획 변경승인 신청
    1 outlets · 1 articlesFirst report Oct 27 17:18 CBC뉴스Regulatory approval
  6. 6
    큐로셀, ‘림카토’ 해외 진출 시동…2027년 튀르키예 허가 목표
    1 outlets · 1 articlesFirst report Oct 22 10:40 한스경제Overseas expansion

Latest Curocell news Korean headlines